DANIELRUBEN MIRANDA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health POMONA, CA NPI 1619629367

General Payments — all program years on this page

$1,717.62

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 51
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,178.78 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,178.7840

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $538.8411
2024 $1,178.7840

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077935226 Janssen Pharmaceuticals, Inc $36.38 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077935250 Janssen Pharmaceuticals, Inc $21.76 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077935314 Janssen Pharmaceuticals, Inc $36.40 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1084829982 Noven Therapeutics, LLC $21.56 07/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101314846 E.R. Squibb & Sons, L.L.C. $27.24 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101314860 E.R. Squibb & Sons, L.L.C. $33.88 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107671933 ABBVIE INC. $21.22 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107671935 ABBVIE INC. $22.05 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107671937 ABBVIE INC. $30.11 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119140315 Otsuka America Pharmaceutical, Inc. $23.99 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555977 Alkermes, Inc. $21.57 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555979 Alkermes, Inc. $16.92 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555981 Alkermes, Inc. $23.46 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555983 Alkermes, Inc. $2.00 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555985 Alkermes, Inc. $21.05 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555987 Alkermes, Inc. $27.51 09/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555989 Alkermes, Inc. $25.67 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555991 Alkermes, Inc. $27.77 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555993 Alkermes, Inc. $124.03 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120555995 Alkermes, Inc. $29.03 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702474 Gilead Sciences, Inc. $23.29 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133958820 Vanda Pharmaceuticals Inc. $28.33 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133958822 Vanda Pharmaceuticals Inc. $125.00 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143554100 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $30.56 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143554104 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.77 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143554107 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.33 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144563551 Indivior Inc. $29.84 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144563553 Indivior Inc. $20.32 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144563555 Indivior Inc. $15.23 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144563557 Indivior Inc. $23.35 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150184690 Tempus AI, Inc $28.97 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150184692 Tempus AI, Inc $29.23 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150945617 Neurocrine Biosciences, Inc. $27.75 08/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151546948 Teva Pharmaceuticals USA, Inc. $8.36 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151546982 Teva Pharmaceuticals USA, Inc. $20.52 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151546984 Teva Pharmaceuticals USA, Inc. $17.85 04/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151546998 Teva Pharmaceuticals USA, Inc. $20.56 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151547008 Teva Pharmaceuticals USA, Inc. $19.61 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151547042 Teva Pharmaceuticals USA, Inc. $41.49 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151547052 Teva Pharmaceuticals USA, Inc. $23.82 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.